mecamylamine and sirolimus

mecamylamine has been researched along with sirolimus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Di Russo, J; Giovannini, MG; Lana, D; Mello, T; Wenk, GL1

Reviews

1 review(s) available for mecamylamine and sirolimus

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

1 other study(ies) available for mecamylamine and sirolimus

ArticleYear
Rapamycin inhibits mTOR/p70S6K activation in CA3 region of the hippocampus of the rat and impairs long term memory.
    Neurobiology of learning and memory, 2017, Volume: 137

    Topics: Animals; Avoidance Learning; CA3 Region, Hippocampal; Male; Mecamylamine; Memory, Long-Term; Memory, Short-Term; Muscarinic Antagonists; Nicotinic Antagonists; Phosphorylation; Rats; Rats, Wistar; Ribosomal Protein S6 Kinases, 70-kDa; Scopolamine; Sirolimus; TOR Serine-Threonine Kinases

2017